Pharmacogenetics to Predict Adverse Events Associated With Antidepressants

[Figure: see text] OBJECTIVES: To determine the association between cytochrome P450 2C19 (CYP2C19) metabolizer status and risk for escitalopram and citalopram, collectively termed (es)citalopram, and sertraline adverse events (AEs) in children. METHODS: In this retrospective cohort study, we used de...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pediatrics
Asıl Yazarlar: Rossow, Katelyn M., Aka, Ida T., Maxwell-Horn, Angela C., Roden, Dan M., Van Driest, Sara L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Academy of Pediatrics 2020
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7786826/
https://ncbi.nlm.nih.gov/pubmed/33234666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2020-0957
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller